tradingkey.logo
๎™๊ฒ€์ƒ‰
์‹œ์žฅ
๊ด€์‹ฌ ๋ชฉ๋ก
๋‰ด์Šค
๋ถ„์„
๋„๊ตฌ
์ข…๋ชฉ ์Šคํฌ๋ฆฌ๋„ˆ
๎™ผ
๎˜
English
็นไฝ“ไธญๆ–‡
เน„เธ—เธข
Tiแบฟng viแป‡t
็ฎ€ไฝ“ไธญๆ–‡
Espaรฑol
Portuguรชs
Deutsch
ํ•œ๊ตญ์–ด
๎˜ณ
ๆ—ฅๆœฌ่ชž
tradingkey.logo
๎™๊ฒ€์ƒ‰
๎™
๎˜

Anavex Life Sciences Corp

AVXL
๎˜ญ๊ด€์‹ฌ ๋ชฉ๋ก์— ์ถ”๊ฐ€
1.095USD
-0.035-3.10%
์‹œ์žฅ ์šด์˜ ์‹œ๊ฐ„ย 11/11, 13:19๏ผˆET๏ผ‰
101.51M์‹œ๊ฐ€์ด์•ก
์†์‹คP/E TTM

Anavex Life Sciences Corp

1.095
-0.035-3.10%
๊ฐœ์š”
๋‰ด์Šค & ๋ถ„์„
๊ธˆ์œต
์ฃผ์‹ ์ ์ˆ˜
๊ธฐ์ˆ 
์˜ˆ์ƒ
์†Œ์œ ๊ถŒ
๋ฐฐ๋‹น๊ธˆ
ํ”„๋กœํ•„
ํ† ๋ก 
์žฌ๋ฌด ์š”์•ฝ์†์ต๊ณ„์‚ฐ์„œ์žฌ๋ฌด์ƒํƒœํ‘œํ˜„๊ธˆ ํ๋ฆ„ํ‘œ์žฌ๋ฌด์ œํ‘œ๊ธฐ์—… ๊ฐ€์น˜ ํ‰๊ฐ€์œ„ํ—˜ ์š”์†Œ

๊ฐœ์š”

๋‰ด์Šค & ๋ถ„์„

๊ธˆ์œต

์ฃผ์‹ ์ ์ˆ˜

๊ธฐ์ˆ 

์˜ˆ์ƒ

์†Œ์œ ๊ถŒ

๋ฐฐ๋‹น๊ธˆ

ํ”„๋กœํ•„

ํ† ๋ก 

์žฌ๋ฌด ์š”์•ฝ์†์ต๊ณ„์‚ฐ์„œ์žฌ๋ฌด์ƒํƒœํ‘œํ˜„๊ธˆ ํ๋ฆ„ํ‘œ์žฌ๋ฌด์ œํ‘œ๊ธฐ์—… ๊ฐ€์น˜ ํ‰๊ฐ€์œ„ํ—˜ ์š”์†Œ

AVXL ์žฌ๋ฌด ๋ฐ์ดํ„ฐ

์Šค๋งˆํŠธํ•œ ํˆฌ์ž์ž๋ฅผ ์œ„ํ•ด ์„ค๊ณ„๋œ ์˜ฌ์ธ์› ๋ฐ์ดํ„ฐ ๋Œ€์‹œ๋ณด๋“œ๋ฅผ ํ†ตํ•ด Anavex Life Sciences Corp์˜ ์žฌ๋ฌด ๋ฐ์ดํ„ฐ๋ฅผ ํ™•์ธํ•˜์„ธ์š”. ๋ณต์žกํ•œ ์žฌ๋ฌด์ œํ‘œ๋ฅผ ์‚ฌ์šฉ์ž ์ •์˜ ๊ฐ€๋Šฅํ•œ ๋ทฐ๋กœ ๊ตฌ์„ฑํ•˜์—ฌ ์žฌ๋ฌด ๋ถ„์„์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. ์ตœ์‹  ์—ฐ๊ฐ„ ์žฌ๋ฌด ๋ณด๊ณ ์„œ์— ์ ‘๊ทผํ•˜๊ฑฐ๋‚˜, ์†์ต๊ณ„์‚ฐ์„œ, ์žฌ๋ฌด์ƒํƒœํ‘œ, ํ˜„๊ธˆ ํ๋ฆ„ํ‘œ๋ฅผ ์‚ฌ์šฉํ•˜์—ฌ ๋ถ„๊ธฐ๋ณ„ ์„ฑ๊ณผ๋ฅผ ๋ถ„์„ํ•˜์„ธ์š”. ์‹ค์‹œ๊ฐ„ ์žฌ๋ฌด ์ง€ํ‘œ๋ฅผ ์†๋์—์„œ ํ™•์ธํ•  ์ˆ˜ ์žˆ์–ด ํšŒ์‚ฌ์˜ ์‹œ์žฅ ๊ฑด์ „์„ฑ์„ ์‹œ๊ฐ„์— ๋”ฐ๋ผ ๊ทธ ์–ด๋Š ๋•Œ๋ณด๋‹ค ์‰ฝ๊ฒŒ ๋ชจ๋‹ˆํ„ฐ๋งํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.
ํ•ต์‹ฌ ์žฌ๋ฌด ๋น„์œจ
์‹œ๊ฐ€์ด์•ก
101.51M
๋ฐฐ๋‹น ์ˆ˜์ต๋ฅ 
0.00
P/E TTM
-2.36
์ฃผ๋‹น์ˆœ์ด์ต
-0.46
์ˆ˜์ต
--
์ˆœ์ด์ต
-46.38M
ROE
-33.63%
ROA
-31.08%
Anavex Life Sciences Corp ์‹ค์  ๋ฐœํ‘œ์ผ๎˜
์ตœ์‹  ์ถœ์‹œ
Aug 28, 2026
EPS / ์˜ˆ์ƒ
-0.54/--
์ˆ˜์ต / ์˜ˆ์ƒ
--/--

์žฌ๋ฌด์ œํ‘œ ์š”์•ฝ

๋ถ„๊ธฐ๋ณ„๎˜ฎ
๋ถ„๊ธฐ๋ณ„+์—ฐ๊ฐ„
๋ถ„๊ธฐ๋ณ„
์—ฐ๊ฐ„
FY2026Q3
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
์žฌ๋ฌด ์ง€ํ‘œ
EPS
154.41%0.08
55.32%-0.06
16.51%-0.11
-7.36%-0.16
-2.90%-0.13
-35.94%-0.14
-10.73%-0.14
-3.59%-0.14
23.60%-0.13
36.85%-0.11
---0.12
---0.14
---0.17
---0.17
---0.62
----
----
----
----
----
์ˆœ์ด์ต
159.08%7.82M
53.09%-5.68M
15.43%-9.83M
-8.42%-13.24M
-6.16%-11.20M
-40.47%-12.11M
-14.53%-11.62M
-8.28%-12.21M
19.54%-10.55M
33.53%-8.62M
29.00%-10.15M
8.79%-11.28M
-25.57%-13.11M
-19.20%-12.97M
-21.95%-14.29M
-21.48%-12.37M
-27.99%-10.44M
-38.54%-10.88M
-96.44%-11.72M
-56.94%-10.18M
๋ถ€์ฑ„๋น„์œจ
----
----
----
----
----
----
----
----
--0.00%
--0.00%
----
----
--0.00%
--0.00%
----
----
----
----
----
----
์†์ต๊ณ„์‚ฐ์„œ๎˜
์˜์—… ์ด์ต
147.33%6.77M
48.75%-6.75M
20.13%-10.83M
-0.73%-14.31M
-2.18%-12.42M
-23.05%-13.17M
-13.18%-13.56M
-9.54%-14.20M
9.58%-12.15M
26.83%-10.70M
16.15%-11.98M
-10.10%-12.97M
-25.79%-13.44M
-34.02%-14.63M
-26.47%-14.29M
-17.86%-11.78M
-33.84%-10.68M
-34.28%-10.91M
-84.82%-11.30M
-47.23%-9.99M
์ˆœ์ด์ต
159.08%7.82M
53.09%-5.68M
15.43%-9.83M
-8.42%-13.24M
-6.16%-11.20M
-40.47%-12.11M
-14.53%-11.62M
-8.28%-12.21M
19.54%-10.55M
33.53%-8.62M
29.00%-10.15M
8.79%-11.28M
-25.57%-13.11M
-19.20%-12.97M
-21.95%-14.29M
-21.48%-12.37M
-27.99%-10.44M
-38.54%-10.88M
-96.44%-11.72M
-56.94%-10.18M
์žฌ๋ฌด์ƒํƒœํ‘œ๎˜
์œ ๋™์ž์‚ฐ
17.29%120.14M
7.21%132.99M
-23.42%103.81M
-27.63%102.43M
-18.94%117.14M
-16.23%124.04M
-12.19%135.57M
-10.31%141.53M
-9.22%144.52M
-0.20%148.07M
1.10%154.39M
-1.50%157.81M
-0.68%159.19M
-5.43%148.37M
-5.51%152.70M
-3.72%160.22M
91.78%160.28M
188.76%156.90M
367.88%161.62M
426.14%166.42M
์œ ๋™ ๋ถ€์ฑ„ ์ด๊ณ„
-32.96%7.69M
-51.47%6.37M
-41.54%8.95M
-2.38%11.47M
81.85%17.38M
5.07%13.13M
22.10%15.30M
6.32%11.75M
-31.83%9.56M
-5.68%12.49M
22.72%12.53M
16.56%11.06M
73.72%14.02M
25.83%13.25M
-5.42%10.21M
2.27%9.48M
3.96%8.07M
31.06%10.53M
47.81%10.80M
33.45%9.27M
์ด ์ž์‚ฐ
17.29%120.14M
7.21%132.99M
-23.42%103.81M
-27.63%102.43M
-18.94%117.14M
-16.23%124.04M
-12.19%135.57M
-10.31%141.53M
-9.22%144.52M
-0.20%148.07M
1.10%154.39M
-1.50%157.81M
-0.68%159.19M
-5.43%148.37M
-5.51%152.70M
-3.72%160.22M
91.78%160.28M
188.76%156.90M
367.88%161.62M
426.14%166.42M
๋ถ€์ฑ„ ์ด๊ณ„
-32.96%7.69M
-51.47%6.37M
-41.54%8.95M
-2.38%11.47M
81.85%17.38M
5.07%13.13M
22.10%15.30M
6.32%11.75M
-31.83%9.56M
-5.68%12.49M
22.72%12.53M
16.56%11.06M
73.72%14.02M
25.83%13.25M
-5.42%10.21M
2.27%9.48M
3.96%8.07M
31.06%10.53M
47.81%10.80M
33.45%9.27M
์ž๋ณธ ์ด๊ณ„
23.63%112.45M
14.16%126.62M
-21.12%94.87M
-29.91%90.96M
-26.08%99.76M
-18.19%110.92M
-15.22%120.26M
-11.57%129.78M
-7.03%134.96M
0.33%135.57M
-0.45%141.85M
-2.64%146.75M
-4.63%145.17M
-7.68%135.12M
-5.52%142.49M
-4.08%150.74M
100.77%152.21M
216.12%146.37M
453.73%150.82M
536.71%157.15M
ํ˜„๊ธˆ ํ๋ฆ„ํ‘œ๎˜
์ˆœ์˜์—…์ด์ต
27.02%-9.10M
41.00%-7.15M
-29.23%-8.60M
-140.62%-12.46M
49.76%-5.86M
-65.62%-12.12M
-13.82%-6.66M
32.31%-5.18M
-37.31%-11.66M
-26.30%-7.32M
-44.65%-5.85M
-8.49%-7.65M
11.94%-8.49M
-65.51%-5.79M
47.31%-4.04M
6.22%-7.05M
-31.74%-9.64M
55.52%-3.50M
-22.70%-7.67M
-85.97%-7.52M
์ˆœ์žฌ๋ฌดํ™œ๋™
100.00%0.00
5030.37%36.32M
11155.06%10.02M
-147.10%-2.14M
-88.29%852.00K
1100.00%708.00K
-95.67%89.00K
-49.46%4.55M
-60.31%7.28M
-77.15%59.00K
84037.73%2.06M
30.28%9.00M
54.90%18.33M
-89.83%258.24K
-99.89%2.44K
-92.25%6.91M
-66.96%11.84M
-90.22%2.54M
-71.82%2.22M
1649.34%89.22M

์ž์ฃผ ๋ฌป๋Š” ์งˆ๋ฌธ

Anavex Life Sciences Corp์˜ ์œ ๋™์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Anavex Life Sciences Corp์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์œ ๋™์ž์‚ฐ์€ 103.81M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -23.42์ž…๋‹ˆ๋‹ค.

Anavex Life Sciences Corp์˜ ์ด์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Anavex Life Sciences Corp์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Anavex Life Sciences Corp์˜ ์ด์ž์‚ฐ์€ 103.81M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -23.42์ž…๋‹ˆ๋‹ค.

Anavex Life Sciences Corp์˜ ์ด๋ถ€์ฑ„๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Anavex Life Sciences Corp์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Anavex Life Sciences Corp์˜ ์ด๋ถ€์ฑ„๋Š” 8.95M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -41.54์ž…๋‹ˆ๋‹ค.

Anavex Life Sciences Corp์˜ ์ด์ž๋ณธ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Anavex Life Sciences Corp์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Anavex Life Sciences Corp์˜ ์ด์ž๋ณธ์€ 94.87M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -21.12์ž…๋‹ˆ๋‹ค.

Anavex Life Sciences Corp์˜ ์ˆœ์˜์—…์†Œ๋“์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Anavex Life Sciences Corp์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Anavex Life Sciences Corp์˜ ์ˆœ์˜์—…์†Œ๋“์€ -50.72M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -0.42์ž…๋‹ˆ๋‹ค.

Anavex Life Sciences Corp์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Anavex Life Sciences Corp์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Anavex Life Sciences Corp์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ 9.43M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -21.22์ž…๋‹ˆ๋‹ค.

Anavex Life Sciences Corp์˜ ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Anavex Life Sciences Corp์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ -0.54์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -5.55์ž…๋‹ˆ๋‹ค.

Anavex Life Sciences Corp์˜ ์ˆœ์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Anavex Life Sciences Corp์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ˆœ์ด์ต์€ -46.38M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -7.85์ž…๋‹ˆ๋‹ค.

Anavex Life Sciences Corp์˜ ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Anavex Life Sciences Corp์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ -43.11์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -31.40์ž…๋‹ˆ๋‹ค.

Anavex Life Sciences Corp์˜ ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Anavex Life Sciences Corp์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ -38.75์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -30.63์ž…๋‹ˆ๋‹ค.

Anavex Life Sciences Corp์˜ ์˜์—…์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Anavex Life Sciences Corp์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์˜์—…์ด์ต์€ -50.72M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -0.42์ž…๋‹ˆ๋‹ค.
tradingkey.logo
์œ„ํ—˜ ๊ฒฝ๊ณ : ์ €ํฌ ์›น์‚ฌ์ดํŠธ์™€ ๋ชจ๋ฐ”์ผ ์•ฑ์€ ํŠน์ • ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ผ๋ฐ˜์ ์ธ ์ •๋ณด๋งŒ์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. Finsights๋Š” ์žฌ์ •์  ์กฐ์–ธ์ด๋‚˜ ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜์ง€ ์•Š์œผ๋ฉฐ, ์ด๋Ÿฌํ•œ ์ •๋ณด ์ œ๊ณต์ด Finsights๊ฐ€ ๊ธˆ์œต ์กฐ์–ธ์ด๋‚˜ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜๋Š” ๊ฒƒ์œผ๋กœ ํ•ด์„๋˜์–ด์„œ๋Š” ์•ˆ ๋ฉ๋‹ˆ๋‹ค.
ํˆฌ์ž ์ƒํ’ˆ์€ ํˆฌ์ž ์›๊ธˆ ์†์‹ค์„ ํฌํ•จํ•œ ์ƒ๋‹นํ•œ ํˆฌ์ž ์œ„ํ—˜์— ๋…ธ์ถœ๋˜์–ด ์žˆ์œผ๋ฉฐ, ๋ชจ๋“  ์‚ฌ๋žŒ์—๊ฒŒ ์ ํ•ฉํ•˜์ง€ ์•Š์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ํˆฌ์ž ์ƒํ’ˆ์˜ ๊ณผ๊ฑฐ ์„ฑ๊ณผ๋Š” ๋ฏธ๋ž˜ ์„ฑ๊ณผ๋ฅผ ๋ณด์žฅํ•˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค.
Finsights๋Š” ์ œ3์ž ๊ด‘๊ณ ์ฃผ๋‚˜ ์ œํœด์‚ฌ๊ฐ€ ์ €ํฌ ์›น์‚ฌ์ดํŠธ๋‚˜ ๋ชจ๋ฐ”์ผ ์•ฑ ๋˜๋Š” ๊ทธ ์ผ๋ถ€์— ๊ด‘๊ณ ๋ฅผ ๊ฒŒ์žฌํ•˜๊ฑฐ๋‚˜ ์ „๋‹ฌํ•  ์ˆ˜ ์žˆ๋„๋ก ํ—ˆ์šฉํ•  ์ˆ˜ ์žˆ์œผ๋ฉฐ, ์‚ฌ์šฉ์ž๊ฐ€ ๊ด‘๊ณ ์™€ ์ƒํ˜ธ์ž‘์šฉํ•˜๋Š” ๋ฐฉ์‹์— ๋”ฐ๋ผ ์ด๋“ค๋กœ๋ถ€ํ„ฐ ๋ณด์ƒ์„ ๋ฐ›์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.
ยฉ ์ €์ž‘๊ถŒ: FINSIGHTS MEDIA PTE. LTD. ๋ชจ๋“  ๊ถŒ๋ฆฌ ๋ณด์œ 
์ด์šฉ ์•ฝ๊ด€
๊ฐœ์ธ์ •๋ณด ์ฒ˜๋ฆฌ๋ฐฉ์นจ
์ฟ ํ‚ค ์ •์ฑ